General Information of Drug (ID: DMP7F9J)

Drug Name
GSK2340274A
Indication
Disease Entry ICD 11 Status REF
Influenza A virus H1N1/H5N1 infection 1E30 Phase 4 [1]
Cross-matching ID
TTD ID
D0LJ5Q

References

1 ClinicalTrials.gov (NCT01114620) Study of GSK Biologicals' Influenza Vaccine Arepanrix in Japanese Adults 65 Years of Age or Older. U.S. National Institutes of Health.